In Vitro and In Vivo Biological Activity of Berberine Chloride against Uropathogenic E. coli Strains Using Galleria mellonella as a Host Model
Open Access
- 28 October 2020
- Vol. 25 (21), 5010
- https://doi.org/10.3390/molecules25215010
Abstract
Berberine is an alkaloid of the protoberberine type used in traditional oriental medicine. Its biological activities include documented antibacterial properties against a wide variety of microorganisms; nonetheless, its use against Escherichia coli strains isolated from urinary infections has not yet been widely investigated in vivo. The emergence of antimicrobial resistance requires new therapeutic approaches to ensure the continued effectiveness of antibiotics for the treatment and prevention of urinary infections. Moreover, uropathogenic Escherichia coli (UPEC) has developed several virulence factors and resistance to routine antibiotic therapy. To this end, several in vitro and in vivo tests were conducted to assess the activity of berberine on uropathogenic E. coli strains. Galleria mellonella as an infection model was employed to confirm the in vivo translatability of in vitro data on berberine activity and its influence on adhesion and invasion proprieties of E. coli on human bladder cells. In vitro pre-treatment with berberine was able to decrease the adhesive and invasive UPEC ability. In vivo treatment increased the larvae survival infected with UPEC strains and reduced the number of circulating pathogens in larvae hemolymph. These preliminary findings demonstrated the efficacy and reliability of G. mellonella as in vivo model for pre-clinical studies of natural substances.Keywords
This publication has 78 references indexed in Scilit:
- In vitro biological assessment of berberis vulgaris and its active constituent, berberine: antioxidants, anti-acetylcholinesterase, anti-diabetic and anticancer effectsBMC Complementary and Alternative Medicine, 2013
- Frequency and antimicrobial resistance patterns of bacteria implicated in community urinary tract infections: a ten-year surveillance study (2000–2009)BMC Infectious Diseases, 2013
- Molecular blueprint of uropathogenicEscherichia colivirulence provides clues toward the development of anti-virulence therapeuticsVirulence, 2012
- Study of the Correlation of Imipenem Resistance with Efflux Pumps AdeABC, AdeIJK, AdeDE and AbeM in Clinical Isolates of Acinetobacter baumanniiChemotherapy, 2012
- Role of UropathogenicEscherichia coliVirulence Factors in Development of Urinary Tract Infection and Kidney DamageInternational Journal of Nephrology, 2012
- Genetic Evidence for Inhibition of Bacterial Division Protein FtsZ by BerberinePLOS ONE, 2010
- Pharmacological and therapeutic effects of Berberis vulgaris and its active constituent, berberinePhytotherapy Research, 2008
- Community-onset Urinary Tract Infections: A Population-based AssessmentInfection, 2007
- Erratum to “The role of P fimbriae for Escherichia coli establishment and mucosal inflammation in the human urinary tract”International Journal of Antimicrobial Agents, 2003
- Genotoxicity of the isoquinoline alkaloid berberine in prokaryotic and eukaryotic organismsMutation Research, 1993